Back

Impact of phase II cardiac rehabilitation on quality of life and functional capacity in patients with pulmonary arterial hypertension

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Outcomes in cardiovascular rehabilitation (1) Cardiovascular Rehabilitation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Al Ma Arij Akbar Lubis

Bunda Thamrin Hospital, Medan (Indonesia)

6 More presentations in this session

Presentation thumbnail
Two-point improvement in short physical performance battery during inpatient cardiac rehabilitation predicts lower rate of all-cause mortality and hospitalization for older patients with heart-failure
Doctor K. Hayakawa (Osaka, JP)
Abstract Slides
Presentation thumbnail
Phase angle is associated with functional capacity after early post-myocardial infarction cardiac rehabilitation – CaRe-ME study
Associate Professor J. Popiolek-Kalisz (Lublin, PL)
Abstract Slides
Presentation thumbnail
Circulatory reserve determines recovery potential during inpatient cardiac rehabilitation
Doctor T. Sugimoto (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Predictors of improved physical performance during cardiac rehabilitation
Doctor M. Kurpaska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Sex-based differences in functional capacity and cardiovascular risk factor control following cardiac rehabilitation programs
Doctor M. Almeida (Vila Nova de Gaia, PT)
Abstract Slides

Access the full session

Session thumbnail
Outcomes in cardiovascular rehabilitation (1)

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac rehabilitation phase 3 and quality of life - patient perception
4 April 2025
thumbnail
Webinar
What's new in pulmonary hypertension: diagnosis and phenotyping? ESC 2022 Clinical Practice Guidelines webinar
3 October 2022
thumbnail
Congress Presentation
Monitoring pulmonary arterial pressures during cardiac rehabilitation using the CardioMEMS device
7 April 2022
thumbnail
Congress Presentation
Quality of life outcomes in patients with pulmonary hypertension receiving prostacyclin therapy: impact of anxiety, depression, sociodemographic and treatment-related factors
14 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources